• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重的α1-抗胰蛋白酶缺乏症(PiZZ)个体患缺血性心脏病的风险低于普通人群。

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.

机构信息

Departments of Respiratory Medicine, Skåne University Hospital, Lund University, Lund, Sweden.

Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.

出版信息

Int J Chron Obstruct Pulmon Dis. 2020 Jun 4;15:1245-1252. doi: 10.2147/COPD.S247377. eCollection 2020.

DOI:10.2147/COPD.S247377
PMID:32606637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7282800/
Abstract

BACKGROUND

Severe alpha-1-antitrypsin deficiency (AATD) is an established risk factor for chronic obstructive pulmonary disease (COPD) and liver disease, but the effect on the incidence of ischemic heart disease (IHD) is not well known. The aim was to evaluate the risk of incident IHD in patients with severe AATD compared with a random sample of the general population, with known smoking habits.

METHODS

AAT-deficient individuals, phenotype PiZZ (n=1545), were included in the Swedish National AATD Register. Controls (n=5883) were selected from population-based cohorts in Northern Sweden. Data on IHD and comorbidities were obtained by nationwide cross-linkage with the Swedish National Patient Register. Risk factors for incident IHD were analyzed using Cox regression, adjusted for age, gender, smoking status and the presence of COPD, hypertension, hyperlipidemia and diabetes.

RESULTS

At inclusion, 46% of the PiZZ individuals and 53% of the controls were never-smokers. During follow-up (median 16 years; range 0.2-23), 8% (n=123) of PiZZ individuals and 12% (n=690) of controls developed IHD. The controls had a significantly higher risk for incident IHD than the PiZZ individuals, with adjusted hazard ratio (HR) of 1.8 (95% CI 1.4-2.3). The risk was higher for controls in both ever-smokers (HR 2.1; 95% CI 1.5-2.9) and never-smokers (HR 1.5; 95% CI 1.1-2.2).

CONCLUSION

PiZZ individuals have a lower risk of developing incident ischemic heart disease than the control subjects with known smoking habits, who had been randomly selected from population-based cohorts.

摘要

背景

严重的α-1-抗胰蛋白酶缺乏症(AATD)是慢性阻塞性肺疾病(COPD)和肝病的既定危险因素,但对缺血性心脏病(IHD)发病率的影响尚不清楚。目的是评估与具有已知吸烟习惯的普通人群的随机样本相比,严重 AATD 患者发生 IHD 的风险。

方法

在瑞典全国 AATD 登记处纳入 AAT 缺陷个体表型 PiZZ(n=1545)。对照(n=5883)从瑞典北部的基于人群的队列中选择。通过与瑞典全国患者登记处的全国性交叉链接获得 IHD 和合并症的数据。使用 Cox 回归分析调整年龄、性别、吸烟状况以及 COPD、高血压、高血脂和糖尿病的存在后,分析发生 IHD 的危险因素。

结果

在纳入时,46%的 PiZZ 个体和 53%的对照从未吸烟。在随访期间(中位数 16 年;范围 0.2-23),8%(n=123)的 PiZZ 个体和 12%(n=690)的对照发生了 IHD。与 PiZZ 个体相比,对照者发生 IHD 的风险明显更高,调整后的风险比(HR)为 1.8(95%CI 1.4-2.3)。在曾吸烟者(HR 2.1;95%CI 1.5-2.9)和从不吸烟者(HR 1.5;95%CI 1.1-2.2)中,对照者的风险更高。

结论

与具有已知吸烟习惯的随机选择的基于人群的队列对照相比,PiZZ 个体发生缺血性心脏病的风险较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d0/7282800/6720e4f5b43a/COPD-15-1245-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d0/7282800/6720e4f5b43a/COPD-15-1245-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d0/7282800/6720e4f5b43a/COPD-15-1245-g0001.jpg

相似文献

1
Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.严重的α1-抗胰蛋白酶缺乏症(PiZZ)个体患缺血性心脏病的风险低于普通人群。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 4;15:1245-1252. doi: 10.2147/COPD.S247377. eCollection 2020.
2
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.通过新生儿筛查确定的瑞典α1-抗胰蛋白酶缺乏队列在37至40岁时的健康状况和肺功能。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 2;12:495-500. doi: 10.2147/COPD.S120241. eCollection 2017.
3
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.严重的α1-抗胰蛋白酶缺乏症会增加静脉血栓栓塞的风险。
J Thromb Haemost. 2021 Jun;19(6):1519-1525. doi: 10.1111/jth.15302. Epub 2021 Apr 9.
4
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.与瑞典普通人群相比,严重α1抗胰蛋白酶缺乏症患者的特定病因死亡率。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 26;11:1663-9. doi: 10.2147/COPD.S109173. eCollection 2016.
5
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.严重的α1-抗胰蛋白酶缺乏症(PiZZ)个体与具有已知吸烟习惯的一般人群的生存比较。
Eur Respir J. 2017 Sep 9;50(3). doi: 10.1183/13993003.00198-2017. Print 2017 Sep.
6
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.42 岁重度 α-1-抗胰蛋白酶缺乏症个体的肺功能和健康状况。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 23;16:3477-3485. doi: 10.2147/COPD.S335683. eCollection 2021.
7
Cancer risk in severe alpha-1-antitrypsin deficiency.严重的α-1-抗胰蛋白酶缺乏症的癌症风险。
Eur Respir J. 2022 Oct 27;60(4). doi: 10.1183/13993003.03200-2021. Print 2022 Oct.
8
Decline in FEV and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency.严重的α-1 抗胰蛋白酶缺乏症个体的 FEV 下降和住院加重。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1075-1083. doi: 10.2147/COPD.S195847. eCollection 2019.
9
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.瑞典国家严重α1-抗胰蛋白酶缺乏症患者登记册中纳入对象的临床概况。
COPD. 2015 May;12 Suppl 1:36-41. doi: 10.3109/15412555.2015.1021909.
10
The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.瑞典 α1-抗胰蛋白酶筛选研究:34 岁时的健康状况以及肺和肝功能。
Ann Am Thorac Soc. 2015 Jun;12(6):807-12. doi: 10.1513/AnnalsATS.201410-452OC.

引用本文的文献

1
Epidemiology and outcomes of alpha-1 antitrypsin deficiency in Sweden 2002-2020: A population-based cohort study of 2286 individuals.2002 - 2020年瑞典α-1抗胰蛋白酶缺乏症的流行病学与转归:一项基于人群的队列研究,涉及2286名个体。
J Intern Med. 2025 Mar;297(3):300-311. doi: 10.1111/joim.20058. Epub 2025 Jan 8.
2
Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions.与α-1抗胰蛋白酶缺乏症(AATD)基因型相关的心血管风险:一项包含Meta回归分析的Meta分析
J Clin Med. 2023 Oct 12;12(20):6490. doi: 10.3390/jcm12206490.
3
Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy.

本文引用的文献

1
Association of Cardiovascular Disease With Respiratory Disease.心血管疾病与呼吸疾病的关联。
J Am Coll Cardiol. 2019 May 7;73(17):2166-2177. doi: 10.1016/j.jacc.2018.11.063. Epub 2019 Mar 4.
2
Liver disease in adults with severe alpha-1-antitrypsin deficiency.成人严重α-1-抗胰蛋白酶缺乏症相关肝病。
J Gastroenterol. 2019 Jun;54(6):541-548. doi: 10.1007/s00535-019-01548-y. Epub 2019 Jan 24.
3
High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia.在因疑似心肌缺血而接受评估的患者中,未确诊慢性阻塞性肺疾病(COPD)的患病率很高。
多组学整合以鉴定扩张型和缺血性心肌病的基因表达及蛋白质特征。
Front Cardiovasc Med. 2023 Feb 13;10:1115623. doi: 10.3389/fcvm.2023.1115623. eCollection 2023.
4
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.抗凝血丝氨酸蛋白酶抑制剂:止血和血栓形成的内源性调节因子。
Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022.
5
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.与α-1 抗胰蛋白酶缺乏症相关的疾病负担:系统和结构化文献回顾。
Eur Respir Rev. 2022 Mar 23;31(163). doi: 10.1183/16000617.0262-2021. Print 2022 Mar 31.
6
Severe α-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis.严重的 α-抗胰蛋白酶缺乏与血压降低和缺血性心脏病风险降低相关:一项对 91540 人的队列研究和荟萃分析。
Respir Res. 2022 Mar 9;23(1):55. doi: 10.1186/s12931-022-01973-3.
Open Heart. 2018 Oct 25;5(2):e000848. doi: 10.1136/openhrt-2018-000848. eCollection 2018.
4
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.α-1-抗胰蛋白酶缺乏症患者的心血管风险。
Respir Res. 2017 Sep 15;18(1):171. doi: 10.1186/s12931-017-0655-1.
5
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.严重的α1-抗胰蛋白酶缺乏症(PiZZ)个体与具有已知吸烟习惯的一般人群的生存比较。
Eur Respir J. 2017 Sep 9;50(3). doi: 10.1183/13993003.00198-2017. Print 2017 Sep.
6
The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database.诊断的α1-抗胰蛋白酶缺乏症及其合并症的患病率:来自大型基于人群的数据库的结果。
Eur Respir J. 2017 Jan 4;49(1). doi: 10.1183/13993003.00154-2016. Print 2017 Jan.
7
High incidence and persistence of airborne allergen sensitization up to age 19 years.高发生率和持续性的空气传播过敏原致敏可至 19 岁。
Allergy. 2017 May;72(5):723-730. doi: 10.1111/all.13053. Epub 2016 Oct 28.
8
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.与瑞典普通人群相比,严重α1抗胰蛋白酶缺乏症患者的特定病因死亡率。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 26;11:1663-9. doi: 10.2147/COPD.S109173. eCollection 2016.
9
The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.瑞典国家严重α1-抗胰蛋白酶缺乏症患者登记册中纳入对象的临床概况。
COPD. 2015 May;12 Suppl 1:36-41. doi: 10.3109/15412555.2015.1021909.
10
2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations.2014 年按国家、年龄和收入划分的缺血性心脏病死亡率的全球地理分析:来自世界卫生组织和联合国的统计数据。
Int J Cardiol. 2014 Jun 15;174(2):293-8. doi: 10.1016/j.ijcard.2014.04.096. Epub 2014 Apr 13.